Items in cart [0] Questions? Call 888-624-8373

HARDBACK + PDF your price: $68.00 add to cart HARDBACK list:$57.95 Web:$52.16 add to cart PDF BOOK your price: $44.50 add to cart PDF CHAPTERS your price: $4.10 select Rights & Permissions Free Resources PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles Spinal Cord Injury: Progress, Promise, and Priorities From Cancer Patient to Cancer Survivor: Lost in Transition Other Related Titles Multiple Sclerosis: Current Status and Strategies for the Future (2001) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 377   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Page 377 Appendix B List of Expert Consultants Dedra S. Buchwald Associate Professor and Director Chronic Fatigue Clinic University of Washington Department of Medicine Howard L. Fields Professor of Neurology and Physiology University of California at San Francisco Robert W. Hamill Chair, Neurology Department University of Vermont David E. Krebs Professor and Director MGH Biomotion Laboratory Harvard University T. Jock Murray Dalhousie Medical School Halifax, Nova Scotia Robert G. Robinson Head, Psychiatry Department University of Iowa Richard Rudick Director, Mellen Center for Multiple Sclerosis Treatment and Research Cleveland Clinic Foundation W. Zev Rymer John G. Searle Professor and Director of Research Rehabilitation Institute of Chicago Northwestern University Marca Sipski Associate Professor of Clinical Rehabilitation Medicine University of Miami School of Medicine Page 377 Front Matter (R1-R18) Executive Summary (1-16) 1 Introduction (17-28) 2 Clinical and Biological Features (29-114) 3 Characteristics and Management of Major Symptoms (115-176) 4 Disease Management and Measurement (177-240) 5 Strategies for Future Research on Disease Mechanisms (241-276) 6 Future Strategies for Therapies (277-324) 7 Building and Supporting the Research Enterprise (325-346) 8 Recommendations (347-368) Appendix A: Committee and Staff Biographies (369-376) Appendix B: List of Expert Consultants (377-378) Appendix C: Workshop Agendas (379-384) Appendix D: Kurtze's Expanded Disability Status Scale (385-386) Appendix E: Drugs Used in the Treatment of MS (387-400) Appendix F: U.S. Social Security Administration's Criteria for Qualifying as Disabled from MS (401-404) Appendix G: Treatments That Have Been Claimed to Be of Benefit in MS (405-412) Index (413-438)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 377
Page 377 Appendix B List of Expert Consultants Dedra S. Buchwald Associate Professor and Director Chronic Fatigue Clinic University of Washington Department of Medicine Howard L. Fields Professor of Neurology and Physiology University of California at San Francisco Robert W. Hamill Chair, Neurology Department University of Vermont David E. Krebs Professor and Director MGH Biomotion Laboratory Harvard University T. Jock Murray Dalhousie Medical School Halifax, Nova Scotia Robert G. Robinson Head, Psychiatry Department University of Iowa Richard Rudick Director, Mellen Center for Multiple Sclerosis Treatment and Research Cleveland Clinic Foundation W. Zev Rymer John G. Searle Professor and Director of Research Rehabilitation Institute of Chicago Northwestern University Marca Sipski Associate Professor of Clinical Rehabilitation Medicine University of Miami School of Medicine

OCR for page 378
Page 378

Representative terms from entire chapter:

richard rudick